DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3031% below fair value
$82.04+0.43 (+0.53%)
Close on Nov 17, 2026Market cap $30.60BP/E 32.3Yield –
DexCom price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
DexCom's price to book ratio was 11.6× on Nov 11, 2026, against 9.1× a year earlier. Over the last 5 years it ranged from 8.3× to 27.2×, with a median of 15.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 11.6× | +2.1 |
| 2025 | Dec 31, 2025 | 9.5× | −5.9 |
| 2024 | Dec 31, 2024 | 15.3× | −5.8 |
| 2023 | Dec 29, 2023 | 21.1× | −2.8 |
| 2022 | Dec 30, 2022 | 24.0× | −3.2 |
| 2021 | Dec 31, 2021 | 27.2× | −7.6 |
| 2020 | Apr 30, 2020 | 34.8× | +18.4 |
| 2019 | Apr 30, 2019 | 16.4× | – |
See a number that looks wrong?